> top > docs > PMC:3218875 > spans > 31905-32131 > annotations

PMC:3218875 / 31905-32131 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T17356 29-39 Gene_expression denotes expression

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T18382 225-226 . denotes .
T18381 219-225 NN denotes cohort
T18380 206-218 JJ denotes well-defined
T18379 202-205 CC denotes and
T18378 196-201 JJ denotes large
T18377 194-195 DT denotes a
T18376 188-193 VBG denotes using
T18375 175-187 NN denotes confirmation
T18374 167-174 VB denotes require
T18373 162-166 MD denotes will
T18372 157-161 DT denotes this
T18371 153-156 CC denotes but
T18370 151-152 , denotes ,
T18369 150-151 NNP denotes ]
T18368 148-150 CD denotes 88
T18367 147-148 NNP denotes [
T18366 138-146 NN denotes efficacy
T18365 128-137 NN denotes treatment
T18364 125-127 CC denotes or
T18363 123-124 , denotes ,
T18362 112-123 NN denotes progression
T18361 110-111 , denotes ,
T18360 101-110 NN denotes diagnosis
T18359 93-100 NN denotes disease
T18358 89-92 IN denotes for
T18357 82-88 NN denotes marker
T18356 80-81 DT denotes a
T18355 77-79 IN denotes as
T18354 70-76 JJ denotes useful
T18353 58-69 RB denotes potentially
T18352 55-57 VBZ denotes is
T18351 46-54 NNS denotes patients
T18350 43-45 NNP denotes RA
T18349 40-42 IN denotes in
T18348 29-39 NN denotes expression
T18347 19-28 VBN denotes increased
T18346 13-18 PRP$ denotes their
T18345 11-12 , denotes ,
T18344 3-11 NN denotes addition
T18343 0-2 IN denotes In
R12199 T18343 T18352 prep In,is
R12200 T18344 T18343 pobj addition,In
R12201 T18345 T18352 punct ",",is
R12202 T18346 T18348 poss their,expression
R12203 T18347 T18348 amod increased,expression
R12204 T18348 T18352 nsubj expression,is
R12205 T18349 T18348 prep in,expression
R12206 T18350 T18351 compound RA,patients
R12207 T18351 T18349 pobj patients,in
R12208 T18352 T18352 ROOT is,is
R12209 T18353 T18354 advmod potentially,useful
R12210 T18354 T18352 acomp useful,is
R12211 T18355 T18354 prep as,useful
R12212 T18356 T18357 det a,marker
R12213 T18357 T18355 pobj marker,as
R12214 T18358 T18357 prep for,marker
R12215 T18359 T18360 compound disease,diagnosis
R12216 T18360 T18358 pobj diagnosis,for
R12217 T18361 T18360 punct ",",diagnosis
R12218 T18362 T18360 conj progression,diagnosis
R12219 T18363 T18362 punct ",",progression
R12220 T18364 T18362 cc or,progression
R12221 T18365 T18366 compound treatment,efficacy
R12222 T18366 T18362 conj efficacy,progression
R12223 T18367 T18369 nmod [,]
R12224 T18368 T18369 nummod 88,]
R12225 T18369 T18357 appos ],marker
R12226 T18370 T18352 punct ",",is
R12227 T18371 T18352 cc but,is
R12228 T18372 T18374 nsubj this,require
R12229 T18373 T18374 aux will,require
R12230 T18374 T18352 conj require,is
R12231 T18375 T18374 dobj confirmation,require
R12232 T18376 T18374 advcl using,require
R12233 T18377 T18381 det a,cohort
R12234 T18378 T18381 amod large,cohort
R12235 T18379 T18378 cc and,large
R12236 T18380 T18378 conj well-defined,large
R12237 T18381 T18376 dobj cohort,using
R12238 T18382 T18374 punct .,require

bionlp-st-ge-2016-coref

Id Subject Object Predicate Lexical cue
T17511 13-18 Anaphor denotes their

2_test

Id Subject Object Predicate Lexical cue
21639951-20470394-4289522 148-150 20470394 denotes 88

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T17865 219-225 NN denotes cohort
T17864 206-218 JJ denotes well-defined
T17863 202-205 CC denotes and
T17862 196-201 JJ denotes large
T17861 194-195 DT denotes a
T17860 188-193 VB denotes using
T17859 175-187 NN denotes confirmation
T17858 167-174 VB denotes require
T17857 162-166 MD denotes will
T17856 157-161 DT denotes this
T17855 153-156 CC denotes but
T17854 151-152 -COMMA- denotes ,
T17853 150-151 -RRB- denotes ]
T17852 148-150 CD denotes 88
T17851 147-148 -LRB- denotes [
T17850 138-146 NN denotes efficacy
T17849 128-137 NN denotes treatment
T17848 125-127 CC denotes or
T17847 123-124 -COMMA- denotes ,
T17846 112-123 NN denotes progression
T17845 110-111 -COMMA- denotes ,
T17844 101-110 NN denotes diagnosis
T17843 93-100 NN denotes disease
T17842 89-92 IN denotes for
T17841 82-88 NN denotes marker
T17840 80-81 DT denotes a
T17839 77-79 IN denotes as
T17838 70-76 JJ denotes useful
T17837 58-69 RB denotes potentially
T17836 55-57 VB denotes is
T17835 46-54 NN denotes patients
T17834 43-45 NN denotes RA
T17833 40-42 IN denotes in
T17832 29-39 NN denotes expression
T17831 19-28 VB denotes increased
T17830 13-18 PRP-DOLLAR- denotes their
T17829 11-12 -COMMA- denotes ,
T17828 3-11 NN denotes addition
T17827 0-2 IN denotes In
R11736 T17828 T17827 arg2Of addition,In
R11737 T17832 T17830 arg1Of expression,their
R11738 T17832 T17831 arg2Of expression,increased
R11739 T17832 T17833 arg1Of expression,in
R11740 T17832 T17836 arg1Of expression,is
R11741 T17832 T17838 arg1Of expression,useful
R11742 T17835 T17833 arg2Of patients,in
R11743 T17835 T17834 arg1Of patients,RA
R11744 T17836 T17851 arg1Of is,[
R11745 T17836 T17855 arg1Of is,but
R11746 T17838 T17836 arg2Of useful,is
R11747 T17838 T17837 arg1Of useful,potentially
R11748 T17838 T17839 arg1Of useful,as
R11749 T17841 T17839 arg2Of marker,as
R11750 T17841 T17840 arg1Of marker,a
R11751 T17841 T17842 arg1Of marker,for
R11752 T17844 T17843 arg1Of diagnosis,disease
R11753 T17844 T17845 arg1Of diagnosis,","
R11754 T17845 T17848 arg1Of ",",or
R11755 T17846 T17845 arg2Of progression,","
R11756 T17848 T17842 arg2Of or,for
R11757 T17848 T17847 arg1Of or,","
R11758 T17850 T17848 arg2Of efficacy,or
R11759 T17850 T17849 arg1Of efficacy,treatment
R11760 T17852 T17851 arg2Of 88,[
R11761 T17853 T17851 arg3Of ],[
R11762 T17855 T17827 arg1Of but,In
R11763 T17855 T17829 arg1Of but,","
R11764 T17855 T17854 arg1Of but,","
R11765 T17856 T17857 arg1Of this,will
R11766 T17856 T17858 arg1Of this,require
R11767 T17856 T17860 arg1Of this,using
R11768 T17858 T17855 arg2Of require,but
R11769 T17858 T17857 arg2Of require,will
R11770 T17858 T17860 modOf require,using
R11771 T17859 T17858 arg2Of confirmation,require
R11772 T17862 T17863 arg1Of large,and
R11773 T17864 T17863 arg2Of well-defined,and
R11774 T17865 T17860 arg2Of cohort,using
R11775 T17865 T17861 arg1Of cohort,a
R11776 T17865 T17862 arg1Of cohort,large
R11777 T17865 T17864 arg1Of cohort,well-defined

sentences

Id Subject Object Predicate Lexical cue
T17445 0-226 Sentence denotes In addition, their increased expression in RA patients is potentially useful as a marker for disease diagnosis, progression, or treatment efficacy [88], but this will require confirmation using a large and well-defined cohort.
T182 0-226 Sentence denotes In addition, their increased expression in RA patients is potentially useful as a marker for disease diagnosis, progression, or treatment efficacy [88], but this will require confirmation using a large and well-defined cohort.

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T18857 13-39 Positive_regulation denotes their increased expression
T18802 43-45 Protein denotes RA

test3

Id Subject Object Predicate Lexical cue
T17418 29-39 Gene_expression denotes expression